PFE — Pfizer Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareConservativeLarge CapSuper Stock

Annual balance sheet for Pfizer, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	12,221	31,069	22,732	12,690	20,477
Net Total Accounts Receivable
Net Total Receivables	7,930	11,479	14,529	15,155	14,777
Total Inventory
Total Other Current Assets
Total Current Assets	35,067	59,693	51,259	43,334	50,358
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	15,293	17,721	19,276	21,864	20,682
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	154,229	181,476	197,205	226,502	213,396
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	25,920	42,671	42,138	47,794	42,995
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	90,991	104,276	101,545	137,487	125,193
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	63,238	77,200	95,660	89,014	88,203
Total Liabilities & Shareholders' Equity	154,229	181,476	197,205	226,501	213,396
Total Common Shares Outstanding
Total Preferred Shares Outstanding